[
  {
    "title": "Dassault Syst\u00e8mes\u2019 CEO Pascal Daloz becomes also Chairman of the Board of Directors of Dassault Syst\u00e8mes",
    "link": "https://www.globenewswire.com/news-release/2026/02/21/3242248/0/en/Dassault-Syst%C3%A8mes-CEO-Pascal-Daloz-becomes-also-Chairman-of-the-Board-of-Directors-of-Dassault-Syst%C3%A8mes.html",
    "description": "<p align=\"right\"><b>Press Release</b><br><b>VELIZY-VILLACOUBLAY, France </b>\u2014<b> February 21, 2026</b></p>",
    "pubDate": "Sat, 21 Feb 2026 18:59 GMT",
    "source": "globenewswire_all"
  },
  {
    "title": "Dassault Syst\u00e8mes annonce la nomination de  Pascal Daloz comme Pr\u00e9sident-Directeur G\u00e9n\u00e9ral  de Dassault Syst\u00e8mes",
    "link": "https://www.globenewswire.com/news-release/2026/02/21/3242248/0/fr/Dassault-Syst%C3%A8mes-annonce-la-nomination-de-Pascal-Daloz-comme-Pr%C3%A9sident-Directeur-G%C3%A9n%C3%A9ral-de-Dassault-Syst%C3%A8mes.html",
    "description": "<p align=\"right\"><b>Communiqu\u00e9 de Presse</b><br><b>VELIZY-VILLACOUBLAY \u2013 21 F\u00e9vrier 2026</b></p>",
    "pubDate": "Sat, 21 Feb 2026 18:59 GMT",
    "source": "globenewswire_all"
  },
  {
    "title": "SKAGI: Samrunavi\u00f0r\u00e6\u00f0um Skaga hf. og \u00cdslandsbanka hf. sliti\u00f0 ",
    "link": "https://www.globenewswire.com/news-release/2026/02/21/3242240/0/is/SKAGI-Samrunavi%C3%B0r%C3%A6%C3%B0um-Skaga-hf-og-%C3%8Dslandsbanka-hf-sliti%C3%B0.html",
    "description": "<p align=\"justify\">Me\u00f0 v\u00edsan til tilkynningar fr\u00e1 6. okt\u00f3ber 2025, \u00fear sem greint var fr\u00e1 undirritun samkomulags um helstu skilm\u00e1la samruna (\u201esamkomulagi\u00f0\u201c) \u00e1 milli \u00cdslandsbanka hf. (\u201e\u00cdslandsbanki\u201c) og Skaga hf. (\u201eSkagi\u201c), tilkynnir stj\u00f3rn Skaga h\u00e9r me\u00f0 um a\u00f0 samrunavi\u00f0r\u00e6\u00f0um f\u00e9laganna hefur veri\u00f0 sliti\u00f0.</p>",
    "pubDate": "Sat, 21 Feb 2026 16:56 GMT",
    "source": "globenewswire_all"
  },
  {
    "title": "\u00c6ndring i ledelsen",
    "link": "https://www.globenewswire.com/news-release/2026/02/21/3242234/0/da/%C3%86ndring-i-ledelsen.html",
    "description": "<p><br>Selskabsmeddelelse nr. 08/2026<br>K\u00f8benhavn, den 21. februar 2026</p>",
    "pubDate": "Sat, 21 Feb 2026 15:02 GMT",
    "source": "globenewswire_all"
  },
  {
    "title": "AnorTech Grants Stock Options",
    "link": "https://www.globenewswire.com/news-release/2026/02/21/3242225/0/en/AnorTech-Grants-Stock-Options.html",
    "description": "<p align=\"justify\">VANCOUVER, British Columbia, Feb.  21, 2026  (GLOBE NEWSWIRE) -- ANORTECH INC. (\u201c<strong>AnorTech</strong>\u201d or the \u201c<strong>Company</strong>\u201d) (TSX Venture Exchange \u201cANOR\u201d; OTCQB \u201cANORF\u201d) has granted incentive stock options under the Company\u2019s stock option plan to directors, employees and consultants to purchase a total of 5,150,000 shares at a price of $0.10 per share. The options vest over 18 months and have a term of five years, subject to the policies of the TSX Venture Ex",
    "pubDate": "Sat, 21 Feb 2026 14:00 GMT",
    "source": "globenewswire_all"
  },
  {
    "title": "Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026",
    "link": "https://www.globenewswire.com/news-release/2026/02/21/3242210/0/en/Abivax-Presents-First-Evidence-of-Anti-Fibrotic-Activity-for-Obefazimod-Alongside-New-Clinical-Efficacy-and-Safety-Analyses-in-Inflammatory-Bowel-Disease-at-ECCO-2026.html",
    "description": "<p align=\"center\"><b>Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026</b></p>",
    "pubDate": "Sat, 21 Feb 2026 11:00 GMT",
    "source": "globenewswire_all",
    "companies": [
      "Biofire",
      "Beacon AI",
      "Grain Weevil",
      "Skyryse"
    ],
    "categories": [
      "milestone"
    ]
  },
  {
    "title": "VCI Global \u6210\u7acb ROBODAX\uff0c\u63a8\u9032\u4eba\u5de5\u667a\u80fd\u539f\u751f\u57fa\u790e\u8a2d\u65bd\u7b56\u7565\uff0c\u6574\u5408\u6a5f\u68b0\u4eba\u81ea\u52d5\u5316\u53ca\u771f\u5be6\u4e16\u754c\u8cc7\u7522\u6578\u78bc\u57fa\u5efa",
    "link": "https://www.globenewswire.com/news-release/2026/02/21/3242208/0/zh-hant/VCI-Global-%E6%88%90%E7%AB%8B-ROBODAX-%E6%8E%A8%E9%80%B2%E4%BA%BA%E5%B7%A5%E6%99%BA%E8%83%BD%E5%8E%9F%E7%94%9F%E5%9F%BA%E7%A4%8E%E8%A8%AD%E6%96%BD%E7%AD%96%E7%95%A5-%E6%95%B4%E5%90%88%E6%A9%9F%E6%A2%B0%E4%BA%BA%E8%87%AA%E5%8B%95%E5%8C%96%E5%8F%8A%E7%9C%9F%E5%AF%A6%E4%B8%96%E7%95%8C%E8%B3%87%E7%94%A2%E6%95%B8%E7%A2%BC%E5%9F%BA%E5%BB%BA.html",
    "description": "\u6b64\u7b56\u7565\u5e73\u53f0\u8209\u63aa\uff0c\u6709\u52a9\u516c\u53f8\u5728\u4eba\u5de5\u667a\u80fd\u63a8\u52d5\u7684\u5be6\u9ad4\u5230\u6578\u78bc\u878d\u5408\u751f\u614b\u7cfb\u7d71\u4e2d\uff0c\u958b\u62d3\u53ef\u64f4\u5c55\u7684\u5546\u696d\u90e8\u7f72 <pre>\u6b64\u7b56\u7565\u5e73\u53f0\u8209\u63aa\uff0c\u6709\u52a9\u516c\u53f8\u5728\u4eba\u5de5\u667a\u80fd\u63a8\u52d5\u7684\u5be6\u9ad4\u5230\u6578\u78bc\u878d\u5408\u751f\u614b\u7cfb\u7d71\u4e2d\uff0c\u958b\u62d3\u53ef\u64f4\u5c55\u7684\u5546\u696d\u90e8\u7f72</pre>",
    "pubDate": "Sat, 21 Feb 2026 09:08 GMT",
    "source": "globenewswire_all"
  },
  {
    "title": "VCI Global \u901a\u8fc7\u6210\u7acb ROBODAX \u63a8\u8fdb\u5176 AI \u539f\u751f\u57fa\u7840\u8bbe\u65bd\u6218\u7565\uff0c\u7edf\u4e00\u673a\u5668\u4eba\u81ea\u52a8\u5316\u4e0e\u73b0\u5b9e\u4e16\u754c\u8d44\u4ea7\u6570\u5b57\u57fa\u7840\u8bbe\u65bd",
    "link": "https://www.globenewswire.com/news-release/2026/02/21/3242208/0/zh-hans/VCI-Global-%E9%80%9A%E8%BF%87%E6%88%90%E7%AB%8B-ROBODAX-%E6%8E%A8%E8%BF%9B%E5%85%B6-AI-%E5%8E%9F%E7%94%9F%E5%9F%BA%E7%A1%80%E8%AE%BE%E6%96%BD%E6%88%98%E7%95%A5-%E7%BB%9F%E4%B8%80%E6%9C%BA%E5%99%A8%E4%BA%BA%E8%87%AA%E5%8A%A8%E5%8C%96%E4%B8%8E%E7%8E%B0%E5%AE%9E%E4%B8%96%E7%95%8C%E8%B5%84%E4%BA%A7%E6%95%B0%E5%AD%97%E5%9F%BA%E7%A1%80%E8%AE%BE%E6%96%BD.html",
    "description": "\u6218\u7565\u5e73\u53f0\u4e3e\u63aa\u52a9\u529b\u516c\u53f8\u5728 AI \u9a71\u52a8\u7684\u5b9e\u4f53 - \u6570\u5b57\u751f\u6001\u7cfb\u7edf\u4e2d\u5b9e\u73b0\u89c4\u6a21\u5316\u5546\u4e1a\u90e8\u7f72 <pre>\u6218\u7565\u5e73\u53f0\u4e3e\u63aa\u52a9\u529b\u516c\u53f8\u5728 AI \u9a71\u52a8\u7684\u5b9e\u4f53 - \u6570\u5b57\u751f\u6001\u7cfb\u7edf\u4e2d\u5b9e\u73b0\u89c4\u6a21\u5316\u5546\u4e1a\u90e8\u7f72</pre>",
    "pubDate": "Sat, 21 Feb 2026 09:08 GMT",
    "source": "globenewswire_all"
  },
  {
    "title": "Founder Group Limited \u6536\u5230 NASDAQ \u5173\u4e8e\u6700\u4f4e\u516c\u4f17\u6301\u80a1\u91cf\u4e0d\u8db3\u7684\u901a\u77e5",
    "link": "https://www.globenewswire.com/news-release/2026/02/21/3242207/0/zh-hans/Founder-Group-Limited-%E6%94%B6%E5%88%B0-NASDAQ-%E5%85%B3%E4%BA%8E%E6%9C%80%E4%BD%8E%E5%85%AC%E4%BC%97%E6%8C%81%E8%82%A1%E9%87%8F%E4%B8%8D%E8%B6%B3%E7%9A%84%E9%80%9A%E7%9F%A5.html",
    "description": "<p align=\"justify\">\u9a6c\u6765\u897f\u4e9a\u96ea\u5170\u83aa\u5dde, Feb.  21, 2026  (GLOBE NEWSWIRE) -- Founder Group Limited (Nasdaq\uff1aFGL\uff0c\u4ee5\u4e0b\u7b80\u79f0\u201cFGL\u201d\u6216\u201c\u516c\u53f8\u201d) \u4eca\u65e5\u5ba3\u5e03\u4e8e 2026 \u5e74 2 \u6708 17 \u65e5\u6536\u5230 Nasdaq Stock Market LLC (\u4ee5\u4e0b\u7b80\u79f0\u201cNasdaq\u201d) \u4e0a\u5e02\u8d44\u683c\u5ba1\u67e5\u90e8\u7684\u901a\u77e5\u51fd\u3002\u51fd\u4ef6\u6307\u51fa\uff0c\u56e0\u516c\u53f8\u5df2\u4e0d\u518d\u6ee1\u8db3 Nasdaq \u8d44\u672c\u5e02\u573a Nasdaq \u4e0a\u5e02\u89c4\u5219 5550(a)(4) \u89c4\u5b9a\u7684 50 \u4e07\u80a1\u6700\u4f4e\u516c\u4f17\u6301\u80a1\u91cf\u8981\u6c42\uff0c\u6545\u4e0d\u518d\u7b26\u5408\u6301\u7eed\u4e0a\u5e02\u7684\u4e0a\u5e02\u89c4\u5219\u3002</p>",
    "pubDate": "Sat, 21 Feb 2026 08:58 GMT",
    "source": "globenewswire_all"
  },
  {
    "title": "Rakovina Therapeutics Announces Upsized Financing Up to $2.0 Million",
    "link": "https://www.globenewswire.com/news-release/2026/02/21/3242195/0/en/Rakovina-Therapeutics-Announces-Upsized-Financing-Up-to-2-0-Million.html",
    "description": "<p align=\"center\"><em>Proposed $1.0 Million Convertible Debenture and Warrant Financing and\u00a0</em><br><em>Concurrent Common Share Private Placement Up to $1.0 Million </em><br><em>Intended to Support Near-Term Operations</em></p>",
    "pubDate": "Sat, 21 Feb 2026 00:50 GMT",
    "source": "globenewswire_all",
    "companies": [
      "Fortera",
      "Asimov",
      "Profluent"
    ],
    "categories": [
      "funding",
      "product"
    ]
  },
  {
    "title": "VERSES Announces Filing of Quarterly Report on Form 10-Q for the Three and Nine-Months Ended December 31, 2025",
    "link": "https://www.globenewswire.com/news-release/2026/02/21/3242192/0/en/VERSES-Announces-Filing-of-Quarterly-Report-on-Form-10-Q-for-the-Three-and-Nine-Months-Ended-December-31-2025.html",
    "description": "<p>VANCOUVER, British Columbia, Feb.  20, 2026  (GLOBE NEWSWIRE) -- VERSES AI Inc. (CBOE: VERS) (OTCQB: VRSSF) (\"VERSES\" or the \"Company\"), a cognitive computing company pioneering next-generation agentic software systems today announced that it has filed its Quarterly Report on Form 10-Q (\u201cQuarterly Report\u201d) for the three months and nine months ended December 31, 2025, with the U.S. Securities and Exchange Commission (\u201cSEC\u201d).</p>",
    "pubDate": "Sat, 21 Feb 2026 00:11 GMT",
    "source": "globenewswire_all"
  },
  {
    "title": "K2 Capital Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Rights, Commencing on February 25, 2026  \u00a0",
    "link": "https://www.globenewswire.com/news-release/2026/02/20/3242185/0/en/K2-Capital-Acquisition-Corp-Announces-the-Separate-Trading-of-its-Class-A-Ordinary-Shares-and-Rights-Commencing-on-February-25-2026.html",
    "description": "<p align=\"justify\">NEW YORK, Feb.  20, 2026  (GLOBE NEWSWIRE) -- K2 Capital Acquisition Corp. (the \"Company\") today announced that, commencing on February 25, 2026, holders of the 13,800,000 units (the \u201cUnits\u201d) sold in the Company\u2019s initial public offering (the \u201cOffering\u201d), including Units sold upon full exercise of the underwriters\u2019 over-allotment option, may elect to separately trade the Class A ordinary shares and rights included in the Units. Any Units not separated will continue to trade on",
    "pubDate": "Fri, 20 Feb 2026 23:00 GMT",
    "source": "globenewswire_all",
    "companies": [
      "Flexport"
    ],
    "categories": [
      "product",
      "ipo"
    ]
  },
  {
    "title": "Helios Fairfax Partners Corporation Closes Amendment to Credit Facility",
    "link": "https://www.globenewswire.com/news-release/2026/02/20/3242181/0/en/Helios-Fairfax-Partners-Corporation-Closes-Amendment-to-Credit-Facility.html",
    "description": "<p align=\"center\"><em>NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES</em></p>",
    "pubDate": "Fri, 20 Feb 2026 22:30 GMT",
    "source": "globenewswire_all"
  },
  {
    "title": "Psyence BioMed Announces Exercise of Put Option by PsyLabs and Strategic Equity Investment",
    "link": "https://www.globenewswire.com/news-release/2026/02/20/3242180/0/en/Psyence-BioMed-Announces-Exercise-of-Put-Option-by-PsyLabs-and-Strategic-Equity-Investment.html",
    "description": "<p align=\"justify\">NEW YORK, Feb.  20, 2026  (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (\u201c<strong>Psyence BioMed</strong>\u201d or the \u201c<strong>Company</strong>\u201d), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine therapies for unmet mental health needs, today announced that Psyence Labs Ltd., a leading developer and manufacturer of pharmaceutical-grade psychedelic compounds (\"<strong>PsyLabs</strong>\") has exercised its rights under a previously disclosed pu",
    "pubDate": "Fri, 20 Feb 2026 22:20 GMT",
    "source": "globenewswire_all",
    "companies": [
      "Zipline",
      "Kinova Robotics"
    ],
    "categories": [
      "funding",
      "product"
    ]
  },
  {
    "title": "Constellation Software Inc. Announces Change to the Date of the Conference Call to Discuss Fourth Quarter Results",
    "link": "https://www.globenewswire.com/news-release/2026/02/20/3242179/0/en/Constellation-Software-Inc-Announces-Change-to-the-Date-of-the-Conference-Call-to-Discuss-Fourth-Quarter-Results.html",
    "description": "<p align=\"justify\">TORONTO, Feb.  20, 2026  (GLOBE NEWSWIRE) -- Constellation Software Inc. (TSX:CSU) announced on February 17, 2026 that it would be holding its fourth quarter conference call on March 10, 2026 at 8:00 am. Constellation has changed the date of the conference call to March 9, 2026 at 8:30 am.</p>",
    "pubDate": "Fri, 20 Feb 2026 22:16 GMT",
    "source": "globenewswire_all"
  },
  {
    "title": "Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)",
    "link": "https://www.globenewswire.com/news-release/2026/02/20/3242177/0/en/Iovance-Biotherapeutics-Reports-Inducement-Grants-under-NASDAQ-Listing-Rule-5635-c-4.html",
    "description": "<p>SAN CARLOS, Calif., Feb.  20, 2026  (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) (\"Iovance\" or the \u201cCompany\u201d), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (\u201cTIL\u201d) therapies for patients with cancer, today announced that on February 19, 2026 (the \u201cDate of Grant\u201d), the Company approved the grant of inducement stock options covering an aggregate of 3,600 shares of Iovance\u2019s common stock to two new, n",
    "pubDate": "Fri, 20 Feb 2026 22:15 GMT",
    "source": "globenewswire_all",
    "companies": [
      "Focused Energy",
      "Fortera",
      "Asimov",
      "Profluent"
    ],
    "categories": []
  },
  {
    "title": "Equinox Gold Announces Filing of 2025 Audited Financial Statements",
    "link": "https://www.globenewswire.com/news-release/2026/02/20/3242175/0/en/Equinox-Gold-Announces-Filing-of-2025-Audited-Financial-Statements.html",
    "description": "Equinox Gold has filed its audited financial statements and MD&A for the three months and year ended December 31, 2025.",
    "pubDate": "Fri, 20 Feb 2026 22:10 GMT",
    "source": "globenewswire_all"
  },
  {
    "title": "Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares ",
    "link": "https://www.globenewswire.com/news-release/2026/02/20/3242170/8624/en/Trinity-Biotech-Receives-Non-Compliance-Notice-Regarding-Nasdaq-Global-Select-Requirement-for-Minimum-Market-Value-of-Publicly-Held-Shares.html",
    "description": "<p align=\"justify\">DUBLIN, Feb.  20, 2026  (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, received notice on February 19, 2026 from the Nasdaq Stock Market LLC (\u201cNasdaq\u201d) that the Company no longer meets the requirement in Nasdaq Listing Rule 5450(b) that listed securities maintain a minimum market value of publicly held shares (\u201cMVPHS\u201d) of $15,000,000,",
    "pubDate": "Fri, 20 Feb 2026 22:00 GMT",
    "source": "globenewswire_all",
    "companies": [
      "Mammoth Biosciences",
      "Focused Energy",
      "Tempus AI",
      "Oxford Nanopore Technologies",
      "Neko Health"
    ],
    "categories": [
      "ipo"
    ]
  },
  {
    "title": "Andrew Peller Limited Announces Change to its Board of Directors",
    "link": "https://www.globenewswire.com/news-release/2026/02/20/3242171/0/en/Andrew-Peller-Limited-Announces-Change-to-its-Board-of-Directors.html",
    "description": "<p align=\"justify\">GRIMSBY, Ontario, Feb.  20, 2026  (GLOBE NEWSWIRE) -- Andrew Peller Limited (TSX: ADW.A / ADW.B) (\u201cAPL\u201d or the \u201cCompany\u201d) announced today that W. James Westlake has resigned from the Company's board of directors to focus on other commitments.</p>",
    "pubDate": "Fri, 20 Feb 2026 22:00 GMT",
    "source": "globenewswire_all"
  },
  {
    "title": "AirBoss to Release 4th Quarter and FY 2025 Earnings on March 4, 2026",
    "link": "https://www.globenewswire.com/news-release/2026/02/20/3242172/0/en/AirBoss-to-Release-4th-Quarter-and-FY-2025-Earnings-on-March-4-2026.html",
    "description": "<p align=\"justify\">NEWMARKET, Ontario, Feb.  20, 2026  (GLOBE NEWSWIRE) -- AirBoss of America Corp. (TSX: BOS) (OTCQX:ABSSF) (the \u201cCompany\u201d or \u201cAirBoss\u201d) today announced that it will release its fourth quarter and unaudited full year 2025 results after markets close on March 4, 2026. The release will be followed by a conference call to discuss the results on Thursday, March 5, 2026, at 9:00 am ET. The Company will file its audited annual consolidated financial statements and related management\u2019s",
    "pubDate": "Fri, 20 Feb 2026 22:00 GMT",
    "source": "globenewswire_all"
  }
]